SARS-CoV-2 Antibody (IgG), Nucleocapsid, Qualitative

About the Test

SARS-CoV-2 Antibody (IgG), Nucleocapsid, Qualitative - This test is intended as an aid in identifying individuals with antibodies to SARS-CoV-2. A positive result indicates an immune response to a recent or prior infection with SARS-CoV-2. This test would not be expected to detect an immune response to a spike vaccine. It is unknown for how long antibodies persist following infection or if the presence of antibodies confers protective immunity. This assay should not be used to diagnose acute SARS-CoV-2 infection.

Biomarkers

SARS-CoV-2 IgG

Biomarker name

Related Articles

Related Tests

Epstein-Barr Evaluation

 by 

Access Med Labs

Serum

The Epstein-Barr Evaluation assesses several antibodies to the Epstein-Barr virus (EBV). It is performed to confirm active, past, or indeterminate infection for EBV-associated infectious mononucleosis.

Lyme Disease Antibody w/ Reflex to Blot (IgG, IgM)

 by 

Access Med Labs

Serum

This test detects antibodies to the bacterium Borrelia burgdorferi. Lyme disease is caused by Borrelia burgdorferi and is transmitted to humans through the bite of infected black-legged ticks. Immunoblot testing will confirm a detected screening result.

Epstein-Barr Early Ag, IgG

 by 

Access Med Labs

Serum

This is a single-marker test measuring IgG antibody response to EBV early antigen.

Candida Albicans Evaluation (IgG, IgA, IgM)

 by 

Access Med Labs

Serum

This test measures IgG, IgA, and IgM antibodies to Candida albicans. Candida-specific antibodies can be significantly elevated in systemic candidiasis. These antibodies have been identified in healthy individuals while poor antibody response is observed in immunocompromised patients.

HIV Ab-Ag Panel, 5th Generation

 by 

Access Med Labs

Serum

This panel determines the absense or presence of antibodies to HIV. The presence of antibody to HIV is not in itself diagnostic of AIDS. Reactive results will be sent for confirmation at an additional charge.